Thu 9 Apr 2026 - Paul Scott's Small/Mid Cap Value Report

Key Takeaways

• MEGP shows 18% earnings growth YoY
• FSG benefits from niche biotech pipeline
• AVCT gains from renewable infrastructure demand
• GHH’s cash flow exceeds industry average
• DEVO targets expanding digital health market

Pulse Analysis

The small‑mid cap segment has become a fertile hunting ground for value investors as large‑cap valuations stretch to historic highs. Paul Scott’s latest report zeroes in on ten companies that exhibit strong fundamentals, modest price‑to‑earnings multiples, and sector tailwinds. By spotlighting firms like MEGP and FSG, the newsletter taps into growth narratives—MEGP’s 18% year‑over‑year earnings surge and FSG’s emerging biotech pipeline—while maintaining a disciplined risk profile typical of value‑oriented strategies.

Beyond raw financials, Scott’s methodology incorporates balance‑sheet resilience and cash‑flow generation, traits that differentiate winners from the crowd in volatile market conditions. Companies such as AVCT and GHH stand out for their exposure to renewable infrastructure and superior operating cash flow, respectively, positioning them to capture incremental demand as governments worldwide accelerate green spending. This focus on sector catalysts aligns with broader macro trends, reinforcing the case for allocating capital to these under‑followed names.

For investors, the report offers more than a ticker list; it provides a framework for assessing small‑mid cap opportunities through a lens of earnings momentum, capital efficiency, and strategic positioning. As institutional money continues to drift toward niche markets in search of higher returns, the insights from Scott’s analysis can serve as a practical guide for constructing a diversified, value‑centric portfolio that balances upside potential with downside protection.